Don't have Telegram yet? Try it now!
https://emerginggrowth.com/bioxytran-inc-otcqb-bixt-licenses-novel-viral-inhibitor-for-covid-19-patients/
Bioxytran, Inc. (OTCQB: BIXT) Licenses Novel Viral Inhibitor for COVID-19 Patients